Created at	Source	Raw Value	Validated value
July 4, 2023, 8 p.m.	usa	Assess the reactogenicity of SCB-2023 vaccine compared to SCB-2019 vaccine;Assess the safety of SCB-2023 vaccine compared to SCB-2019 vaccine;Assess the safety of SCB-2023 vaccine compared to SCB-2019 vaccine;To demonstrate that SCB-2023 vaccine elicits an immune response superior to SCB-2019 for Omicron BA.5;To demonstrate that SCB-2023 vaccine elicits an immune response superior to SCB-2019 for Omicron XBB.1.5	Assess the reactogenicity of SCB-2023 vaccine compared to SCB-2019 vaccine;Assess the safety of SCB-2023 vaccine compared to SCB-2019 vaccine;Assess the safety of SCB-2023 vaccine compared to SCB-2019 vaccine;To demonstrate that SCB-2023 vaccine elicits an immune response superior to SCB-2019 for Omicron BA.5;To demonstrate that SCB-2023 vaccine elicits an immune response superior to SCB-2019 for Omicron XBB.1.5